Anzenna

Annzenna has leveraged $8.7 million in development funds and 7 active US Patents to create a unique bio-identification device.

Company Summary

Anzenna’s programmable bio-identification device provides advantages include lower cost, simplicity, timeliness of responses, accuracy and flexibility and the ability to pack a large number of transistors on a single diagnostic chip which supports the identification of an extended list of unique biomarkers with a single test. Seasoned Senior Mgt (Tech and Bus dev) looking to partner w/ established business in health car, environment, water purity

Team

  • Bruce Niswander
    CFO, COO

    Prior to Anzenna, Mr. Niswander was founder and director of the Global business incubator. He was also the director of technology transfer at NYU Poly, and developed and commercialized the Varick Street Incubator in partnership with NYC which delivered $520 million of economic impact to the NYC market. Varick Streets 1st 50 graduates had a value of over $720 million. He has completed 6 prior startups. He is CFA, JD, MBA and Finance degrees.

  • Kalle Levon
    CEO, CTO

    Dr. Levon has over 35 years of advanced, bio-chemical research experience in the area of “organic electronics”. Dr. Levon has been on the faculty at Brooklyn Polytechnic Institute of NYU since 1989 . He is an expert in the areas of anticorrosive protective coatings, and electrochemical biosensors. Dr. Levon served as the head of the Chemistry Depart, the Director of the Polymer Research Inst.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free